People Biography

Dr. Khalid A. Fakhro is the Chief Research Officer at Sidra Medicine and Chair of the Precision Medicine Program.

Dr Fakhro is also involved in capacity building and education via faculty appointments at Weill-Cornell Medicine - Qatar and at Hamad bin Khalifa University, where he teaches classes and mentors the next students in human genetics and genomic medicine.

As the CRO for Sidra Medicine, Dr. Fakhro is responsible for designing and implementing the healthcare organization’s ambitious research strategy to advance precision medicine for women and children in Qatar. The strategy aims to place Sidra Medicine among the top destinations for personalized care in the world, leveraging next-generation technologies to enhance disease diagnosis and implement advanced therapies for patients. Under his leadership, scientists in the Research Branch at Sidra Medicine, have made important strides in identifying genes and biomarkers of diseases affecting women and children, particularly those with rare conditions, and launched clinical trials that promise to deliver advanced therapies to patients in need. 

Prior to being appointed as CRO, Dr Fakhro led the Human Genetics Department at Sidra Medicine and launched the first Mendelian disease and precision medicine programs, heading these ambitious efforts where research in genomics and personalized medicine became embedded in the pathway of patient care. His lab specifically works on gene discovery in rare diseases (including autism), fertility genetics, structural variation, and genomic characterization of the Qatari population using multiple ‘omic technologies.